HUP0401959A2 - A VII-es faktor és PAI-1 polipeptideket tartalmazó gyógyszerészeti összetétel - Google Patents

A VII-es faktor és PAI-1 polipeptideket tartalmazó gyógyszerészeti összetétel

Info

Publication number
HUP0401959A2
HUP0401959A2 HU0401959A HUP0401959A HUP0401959A2 HU P0401959 A2 HUP0401959 A2 HU P0401959A2 HU 0401959 A HU0401959 A HU 0401959A HU P0401959 A HUP0401959 A HU P0401959A HU P0401959 A2 HUP0401959 A2 HU P0401959A2
Authority
HU
Hungary
Prior art keywords
polypeptides
pai
factor vii
pharmaceutical composition
vii polypeptides
Prior art date
Application number
HU0401959A
Other languages
English (en)
Inventor
Rasmus Rojkjaer
Original Assignee
Novo Nordisk Health Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Health Care Ag filed Critical Novo Nordisk Health Care Ag
Publication of HUP0401959A2 publication Critical patent/HUP0401959A2/hu
Publication of HUP0401959A3 publication Critical patent/HUP0401959A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A találmány olyan összetételekre vonatkozik, melyek VII-es faktor vagyVII-es faktorral rokon polipeptideket és PAI-1 vagy a PAI-1-gyel rokonpolipeptideket tartalmaznak, amelyeket a vérzési események kezelésérelehet felhasználni. Ó
HU0401959A 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides HUP0401959A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101671 2001-11-09
PCT/DK2002/000735 WO2003039580A1 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides

Publications (2)

Publication Number Publication Date
HUP0401959A2 true HUP0401959A2 (hu) 2004-12-28
HUP0401959A3 HUP0401959A3 (en) 2009-03-30

Family

ID=8160829

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401959A HUP0401959A3 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides

Country Status (15)

Country Link
EP (1) EP1446146A1 (hu)
JP (1) JP2005510514A (hu)
KR (1) KR20050043733A (hu)
CN (1) CN1596122A (hu)
AU (1) AU2002340778B2 (hu)
BR (1) BR0213952A (hu)
CA (1) CA2464614A1 (hu)
CZ (1) CZ2004535A3 (hu)
HU (1) HUP0401959A3 (hu)
IL (1) IL161523A0 (hu)
NO (1) NO20042379L (hu)
PL (1) PL370118A1 (hu)
RU (1) RU2304980C2 (hu)
WO (1) WO2003039580A1 (hu)
ZA (1) ZA200403270B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009045412A2 (en) * 2007-10-01 2009-04-09 American Diagnostica, Inc. Methods of treatment using modified plasminogen activator inhibitor type-1 molecules
WO2020103930A1 (zh) * 2018-11-22 2020-05-28 上海科技大学 噻唑并环类化合物、其制备方法、中间体和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7907398A (en) * 1997-06-23 1999-01-04 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
AT409335B (de) * 1998-11-10 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen
AU2001254624A1 (en) * 2000-05-03 2001-11-12 Novo-Nordisk A/S Human coagulation factor vii variants

Also Published As

Publication number Publication date
JP2005510514A (ja) 2005-04-21
PL370118A1 (en) 2005-05-16
BR0213952A (pt) 2004-08-31
RU2004117535A (ru) 2005-04-10
WO2003039580A1 (en) 2003-05-15
HUP0401959A3 (en) 2009-03-30
NO20042379L (no) 2004-06-08
EP1446146A1 (en) 2004-08-18
KR20050043733A (ko) 2005-05-11
IL161523A0 (en) 2004-09-27
RU2304980C2 (ru) 2007-08-27
CN1596122A (zh) 2005-03-16
CA2464614A1 (en) 2003-05-15
CZ2004535A3 (cs) 2005-01-12
AU2002340778B2 (en) 2007-08-02
ZA200403270B (en) 2004-11-08

Similar Documents

Publication Publication Date Title
HUP0303143A2 (hu) A VII-es faktor és a IX-es faktor polipeptidek kombinált alkalmazása
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
IL159022A0 (en) Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
HUP0402497A3 (en) Pharmaceutical compositions containing two activ ingredients and their uses
HUP0301163A3 (en) 7-substituted tetracycline dervatives, pharmaceutical compositions containing them and their use
TW200505875A (en) Novel compounds
IL203923A (en) Benzamide compounds, pharmaceutical compositions comprising them, use thereof in the preparation of medicaments and as medicaments and processes for the preparation of such compounds
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
PL375621A1 (en) Pharmaceutical compositions comprising flavonoids and menthol
HUP0400976A2 (hu) VII-es faktor polipeptideket és XI-es faktor polipeptideket tartalmazó gyógyszerészeti összetételek
SE9802729D0 (sv) Novel Compounds
DE60120712D1 (en) Kallikrein gen
AP1787A (en) Novel perindopril salt and pharmaceutical compositions containing same.
HRP20050024A2 (en) Pegylated t20 polypeptide
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
MXPA03010158A (es) Sulfonamidas.
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
SI1411921T1 (sl) Farmacevtski sestavki, ki vsebujejo terbinafin, in njihova uporaba
AU2003294785A1 (en) Hair treatment compositions
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
MXPA03010683A (es) Composicion que contiene un peptido y un pigmento y el uso del mismo para oscurecer la piel.
IL173626A0 (en) Small peptides and oral pharmaceutical compositions containing the same
HUP0303469A3 (en) Phtalazinon-derivatives, their use and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees